Torulopsis

06/01/1988 - "5-Fluorocytosine eradicated Torulopsis funguria in 4 of 6 patients in whom it was used. "
11/01/1978 - "Phenotypes of resistance to fluorophyrimidines and the occurence of 5-fluorocytosine resistant mutants in Candida and Torulopsis yeasts."
01/01/1973 - "In vitro activity of 5-fluorocytosine against Candida and Torulopsis species."
01/30/1981 - "The sensitivity to nystatin, 5-fluorocytosine (5-FC) or both was studied for 131 clinical isolates of Candida albicans, 47 of Candida parapsilosis, 34 of Candida tropicalis, 7 of Candida guilliermondii, 28 of Torulopsis glabrata and 1 of Torulopsis candida. "
01/01/1993 - "The activities of amphotericin B, flucytosine, and ketoconazole were tested against 100 coded isolates of Candida albicans, Candida tropicalis, Candida parapsilosis, Candida lusitaniae, Torulopsis (Candida) glabrata, and Cryptococcus neoformans. "

11/01/1996 - "albicans, 27 Candida tropicalis, 22 Torulopsis (Candida) glabrata, and 29 other yeast isolates were tested by the germ tube production method and three tests for enzyme production, with the API 20C method used as a "gold standard." All three enzymatic methods evaluated provided more objective and rapid nonmicroscopic alternatives to the germ tube test and may be used to accurately distinguish C. "
01/01/1992 - "Commercial preparations of alcohol dehydrogenases from the cytoplasm of horse liver cells and yeast cells, as well as the enzyme from the cytoplasm of Trichosporon pullulans cells was completely inhibited by 1 mM pyrazol, while alcohol dehydrogenases from Candida utilis and Saccharomyces carlsbergensis were inhibited only by 25% and the enzymes from Saccharomyces cerevisiae and Torulopsis candida by 30 and 38%, respectively. "
01/01/1990 - "From among the strains, Rhodotorula minuta [corrected] and Torulopsis candida were selected for examination of the existence of yeast mitochondrial isoenzymes, because these strains showed two clear activity bands on the zymogram and contained a high amount of the enzyme. "
01/01/1976 - "Adaptation of yeast torulopsis candida to D-arabinose, D-lyxose and L-oxylose is shown to be due to the appearance of a new enzyme which catalyzes the reduction of these pentoses to D-arabitol and xylitol, respectively. "

01/01/1982 - "The introduction of clotrimazole into the therapy of vaginal Candida and Torulopsis infections has significantly shortened the previously customary duration of treatment and reduced the frequency of dosage of the active ingredient. "

01/01/2002 - "A study was made of structural organization of Torulopsis sphaerica cells irradiated with He-Ne (lambda = 632.8 nm; dose--460 J/m2) and then cultured in the nutrient with 1% glucose and O2 for 6 h. "
07/01/1981 - "The dynamics of metabolite excretions by Candida guilliermondii, Candida zeylanoides and Torulopsis candida was studied during their batch cultivation in media with glucose excess and low concentrations of N, P or S sources; the latter were the growth limiting factors and determined the transition to phase of retardation and the stationary phase of growth. "
09/01/1978 - "The operation of CrETP was found to differ among various yeasts growing on glucose: it could function during both the exponential phase and limitation of growth (Torulopsis candida), or only in the conditions of growth limitation (Candida tropicalis, C. "
03/01/1975 - "The rate of glucose utilization is lower if Torulopsis latvica is grown on a medium with gradual addition of glucose cf. "
03/01/1975 - "[Dynamics of consumption and threshold concentration of glucose during the culture of Torulopsis latvica]."

09/01/1994 - "A comparison of the E test, the broth microdilution test, and the reference broth macrodilution susceptibility test of the National Committee for Clinical Laboratory Standards for fluconazole susceptibility testing was performed with 238 clinical isolates of Candida species and Torulopsis (Candida) glabrata. "
09/01/1993 - "However, Torulopsis (Candida) glabrata assumed a much higher proportion of fungemias (75%) among patients receiving fluconazole. "
12/01/1994 - "Torulopsis (Candida) glabrata (three patients), Cryptococcus terreus and Candida tropicalis (mixed in one patient) caused fungemia in four patients in the fluconazole group; Candida albicans caused six of eight fungemic episodes in the controls. "
10/01/1995 - "Fluconazole and itraconazole MICs were determined by both the standard macrodilution method of the National Committee for Clinical Laboratory Standards and a colorimetric broth microdilution method for 140 isolates of Torulopsis (Candida) glabrata obtained over a 15-year period. "
01/01/1990 - "Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole."

01/01/1977 - "During their earlier studies Aksoycan and his colleagues showed also the antigen relationship between Saccharomycopsis ludwigii, Syringospora albicans, Syringospora claussenii, Syringospora stellatoidea, Metschnikowia, Torulopsis and Salmonella cholerae suis O 6, 7 antigen (2, 3, 4, 5, 6, 7, 8)."
12/01/1977 - "[The grouping of torulopsis species according to the Salmonella cholerae-suis O 6,7 antigens. "
08/01/1977 - "Absorption and agglutination cross test demonstrated common antigen factors in the tested Torulopsis species and in S. "
08/01/1977 - "[On the similarity of antigen between torulopsis and salmonella. "
05/01/1977 - "Absorption and agglutination cross test demonstrated common antigen factors in the tested Torulopsis species and in S. "

06/01/1986 - "Ketoconazole also proved fungicidal against Pityrosporon canis and strongly inhibitory on Cryptococcus neoformans and Torulopsis famata at the lowest used concentration. "
01/01/1990 - "Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole."
03/01/1995 - "We performed a prospective and double-blinded study to compare the Etest and National Committee for Clinical Laboratory Standards (Villanova, Pa.) broth macrodilution methods for determining the MICs of fluconazole, itraconazole, and ketoconazole for 100 clinical isolates (25 Candida albicans, 25 Cryptococcus neoformans var. neoformans, 20 Torulopsis [Candida] glabrata, 15 Candida tropicalis, and 15 Candida parapsilosis). "
01/01/1993 - "The activities of amphotericin B, flucytosine, and ketoconazole were tested against 100 coded isolates of Candida albicans, Candida tropicalis, Candida parapsilosis, Candida lusitaniae, Torulopsis (Candida) glabrata, and Cryptococcus neoformans. "
12/01/1989 - "The susceptibility of several strains of Candida and Torulopsis to saperconazole, a new triazole antifungal compound, was compared to that of ketoconazole. "

01/01/1989 - "During itraconazole prophylaxis a shift from classic pathogens such as Aspergillus and Candida, to Fusarium, Torulopsis and Mucor, may be seen."
01/01/1987 - "Itraconazole was active against dermatophytes (271 strains), Candida species (1,303), Cryptococcus neoformans (27), Torulopsis species (170), Pityrosporum species (40), Aspergillus species (87), Sporothrix schenckii (12), dimorphic fungi, Dematiaceae, and various other organisms. "
10/01/1995 - "Fluconazole and itraconazole MICs were determined by both the standard macrodilution method of the National Committee for Clinical Laboratory Standards and a colorimetric broth microdilution method for 140 isolates of Torulopsis (Candida) glabrata obtained over a 15-year period. "
03/01/1995 - "We performed a prospective and double-blinded study to compare the Etest and National Committee for Clinical Laboratory Standards (Villanova, Pa.) broth macrodilution methods for determining the MICs of fluconazole, itraconazole, and ketoconazole for 100 clinical isolates (25 Candida albicans, 25 Cryptococcus neoformans var. neoformans, 20 Torulopsis [Candida] glabrata, 15 Candida tropicalis, and 15 Candida parapsilosis). "

01/01/1995 - "This study was performed to identify pathological fungi of eight species [Aspergillus fumigatus, Candida albicans, Torulopsis (Candida) glabrata, Cryptococcus neoformans, Fusarium anthophilum, Rhizopus oryzae, Sporothrix schenckii and Trichosporon beigelii] in formalin-fixed, paraffin-embedded tissue sections by indirect immunoperoxidase staining. "

01/01/1989 - "Scanning electron microscope study of Torulopsis ethanolitolerans prepared by glutaraldehyde--thiosemicarbohydrazide procedure."

10/01/1990 - "A small number of patients developed recurrent and often chronic Torulopsis vaginitis unresponsive to conventional therapy. "
01/01/1989 - "The data suggest that clinical difficulties encountered in the therapy of torulopsis vulvovaginitis probably represent the inability of intravaginal medication to eradicate urethral/urinary bladder colonization and subsequent reinfection rather than true therapeutic failures."
01/01/1982 - "The introduction of clotrimazole into the therapy of vaginal Candida and Torulopsis infections has significantly shortened the previously customary duration of treatment and reduced the frequency of dosage of the active ingredient. "

01/01/1982 - "The introduction of clotrimazole into the therapy of vaginal Candida and Torulopsis infections has significantly shortened the previously customary duration of treatment and reduced the frequency of dosage of the active ingredient. "

01/01/2002 - "[Morphometric study of yeast cells of Torulopsis sphaerica after He-Ne-laser irradiation]."
03/01/2001 - "Unusual contacts between boundary membranes in mitochondria of the yeast Torulopsis sphaerica cells whose precursors were exposed to He-Ne laser radiation."
01/01/2004 - "We studied the ultrastructure of Torulopsis sphaerica yeast cells irradiated with He-Ne laser (lambda = 632.8 nm, dose--460 J/m2) and then cultured for 6 h in the nutrient with 1% glucose by aeration. "

11/01/1986 - "We described the first documented case of intravenous-catheter-associated fungemia caused by Torulopsis candida (Candida famata). "
03/01/2002 - "Here we describe what appears to be the first case of a right atrial thrombus superinfected with the yeast Torulopsis (Candida) glabrata and attached to an indwelling superior vena cava catheter that was not used for parenteral nutrition. "
01/01/1999 - "A strain of yeast labeled Torulopsis candida, which was isolated from a clinical specimen in Canada and reported as a new opportunistic pathogen causing intravenous catheter-associated fungemia, was found to be a strain of Candida palmioleophila in a DNA-DNA reassociation experiment."
01/01/1979 - "The new therapeutic methods based on antibiotics, corticosteroids and immunosuppressors and the new medicosurgical techniques (catheters, monitoring in intensive-care units, open-heart surgery) modify the host, favorise the adaptation and introduction f endogenous and exogenous yeast-like fungi and thus create a new pathology characterized by deep visceral or septicemic infections due to yeasts belonging to the genera Candida, Torulopsis, Cryptococcus, Trichosporon, Rhodotorula, and Saccharomyces. "

05/01/2005 - "This report describes the successful long-term survival of a patient with Torulopsis TIPS stent infection."